PTN and osteosarcoma: In addition, Qin et al. reported that luteolin, a flavonoid compound, inhibited the multidrug resistance of osteosarcoma cells through increasing the packaging of miR-384 into exosomes and then suppressing the PTN/β-catenin/MDR1 signaling axis [53].